Paracetamol DC Granules are pharmaceutical-grade granulated materials developed for direct-compression and oral solid dosage formulation applications. Direct compression requires appropriate control of particle size, flowability, bulk density, compressibility, compactability and blend uniformity. Granulation and particle engineering can help establish physical characteristics suitable for downstream blending and tablet compression.
Paracetamol, also known as acetaminophen, has the molecular formula C8H9NO2, molecular weight 151.16 g/mol and CAS Number 103-90-2. The chemical and physical properties of paracetamol are important considerations during formulation development because particle size, crystal characteristics and powder flow can influence tablet manufacturing performance.
Paracetamol DC Granules are engineered granules containing paracetamol and suitable formulation components, developed for direct-compression applications. The DC designation refers to the intended processing format in which the granulated material can be blended with suitable excipients and compressed into the required solid dosage form.
Direct compression places significant importance on the physical properties of particulate materials. Particle-size distribution, granule morphology, density and flow characteristics can affect powder transfer, blending, die filling and compression.
Published research has demonstrated that paracetamol particle size can influence flowability during direct-compression formulation development. Other research has shown that the preparation method and mechanical properties of paracetamol granules can affect compactability and tablet structure.
Paracetamol has the molecular formula C8H9NO2 and molecular weight 151.16 g/mol. Its CAS Number is 103-90-2.
The active material can exist with different particle and crystal characteristics, and these physical properties can influence processing performance. For direct-compression formulations, the chemical identity of paracetamol alone does not determine manufacturability. Particle size, morphology, surface characteristics, density and interaction with excipients can all influence the final formulation.
This makes appropriate particle characterization an important part of Paracetamol DC Granules development.
Direct compression is a formulation process in which appropriately characterized particulate materials are blended and compressed into tablets. Compared with processes requiring a separate wet-granulation step immediately before compression, direct compression can simplify processing when the material has suitable flow and compression properties.
Paracetamol DC Granules can be considered for:
The final performance depends on the complete formulation, including paracetamol loading, excipient selection, granule characteristics and compression conditions.
Particle size is an important quality characteristic for Paracetamol DC Granules. Changes in particle size can influence flowability, packing, segregation, die filling and compression.
Relevant particle-size measurements may include:
The appropriate acceptance range should be established from the actual product specification. A universal D10, D50 or D90 value should not be assigned without product-specific data.
Research on paracetamol direct-compression formulations has demonstrated that particle size can have a significant influence on powder flow and tablet manufacturing behavior.
Flowability is one of the most important characteristics for direct-compression materials. Consistent flow can support reliable transfer, hopper feeding and die filling.
Paracetamol DC Granules may be evaluated using:
The actual limits should be based on the approved product specification and validated test methods.
Good flow behavior can reduce variability during material handling and help maintain consistent filling of the tablet tooling. However, flowability should be assessed together with compressibility and compactability because a material with good flow does not necessarily produce tablets with suitable mechanical properties.
Compressibility describes the change in volume of a particulate material under applied pressure, while compactability describes the ability of the material to form a mechanically suitable compact.
Paracetamol has been widely studied in relation to compression behavior. Research has shown that particle properties and preparation methods can influence deformation, fragmentation and compactability.
For Paracetamol DC Granules, formulation development may therefore evaluate:
These characteristics should be evaluated using the complete formulation rather than the granules alone.
Granule morphology can influence flow, packing and compression. More uniform granules can provide more predictable material movement and may reduce segregation during processing.
Important characteristics may include:
The desired morphology depends on the manufacturing process and formulation requirements.
Content uniformity is an important consideration for pharmaceutical formulations. Consistent distribution of paracetamol within the granulated material and subsequent blend can contribute to reproducible dosage-unit performance.
Development may include evaluation of:
The applicable acceptance criteria should be established through validated analytical procedures and the approved finished-product specification.
Paracetamol DC Granules can be developed with suitable excipients to achieve the required processing and tablet characteristics. Excipients can influence flow, compression, disintegration, lubrication and overall tablet performance.
Formulation development may evaluate the interaction between paracetamol particle characteristics and excipient properties. Research involving paracetamol and microcrystalline-cellulose mixtures has shown that material properties such as surface characteristics, density and friction can influence tabletability.
A systematic formulation-development approach can help identify appropriate material characteristics and processing conditions for consistent direct-compression performance.
During tablet development, Paracetamol DC Granules may be evaluated under different compression conditions. The resulting tablets can be assessed for mechanical strength, friability, disintegration and dissolution.
Important tablet attributes may include:
The appropriate compression conditions depend on the formulation and tablet design.
Dissolution performance depends on the complete formulation and can be influenced by particle size, granule structure, excipient selection, compression force, tablet porosity and disintegration characteristics.
Paracetamol DC Granules should therefore be evaluated using the applicable validated dissolution procedure. A specific dissolution percentage or time should not be claimed for the granules unless supported by product-specific validated data.
Particle size and crystal characteristics can influence the behavior of paracetamol-containing tablets, making material characterization important during formulation development.
Quality control for Paracetamol DC Granules should combine chemical and physical characteristics.
Potential quality attributes include:
Not every parameter is necessarily applicable to every commercial product. The final specification should reflect the actual manufacturing process and approved product requirements.
Manufacturing Paracetamol DC Granules requires consistent control of raw materials, granulation, drying where applicable, sizing and blending.
Important process considerations may include:
Consistency between batches is important because changes in particle size, moisture, density or morphology can influence downstream direct-compression performance.
Paracetamol DC Granules may be used in formulation-development applications such as:
The final formulation and manufacturing process should be established according to the intended product design and validated process requirements.
Quality control should address both chemical identity and physical performance. Identification and assay help confirm chemical quality, while particle size, density and flow testing provide information about processing behavior.
Depending on the approved specification, testing may include identification, assay, related substances, moisture, particle-size distribution, bulk density, tapped density, flowability, fines, compressibility, compactability, content uniformity and dissolution.
Numerical acceptance criteria for finished Paracetamol DC Granules should come from the actual product specification and validated analytical methods rather than being copied from unrelated research formulations.
| Parameter | Specification |
|---|---|
| Appearance | White to off-white granules |